8
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T36579 | GLP-1R Agonist DMB | Glucagon Receptor | |
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor). | |||
T70961 | Dmb-rifampicin | Others | |
Dmb-rifampicin is an inhibitor of nucleic acid polymerases. | |||
T72383 | 3,3-Dimethyl-1-butanol | Neohexanol,DMB,DMB ; Neohexanol | Others |
3,3-Dimethyl-1-butanol (DMB) is an orally active compound that inhibits trimethylamine (TMA) and trimethylamine N-oxide (TMAO), along with the signaling pathways of p65 NF-κB and TGF-β1/Smad3. It holds potential for use ... | |||
T66614 | Fmoc-(Dmb)Gly-OH | ||
Fmoc-(Dmb)Gly-OH is a useful organic compound for research related to life sciences. The catalog number is T66614 and the CAS number is 166881-42-1. | |||
T36696 | DMBA | 7,12-Dimethylbenzanthracene,7,12-DMBA,7,12-Dimethylbenz[a]anthracene | Apoptosis |
DMBA (7,12-Dimethylbenz[a]anthracene) induces leukemia, hepatocellular carcinoma, and mammary carcinoma in rats, and programmed cell death (apoptosis) in B-cell lymphomas in A20.1 mice. | |||
T71101 | DMBT | Others | |
DMBT is an inhibitor of invasion and metastasis through Akt/GSK-3β/β-catenin pathway in B16BL6 cells. | |||
T18705 | SPDMB | Others | |
SPDMB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs). | |||
T28006 | MDMB-CHMINACA | (S)-MDMB-CHMINACA | Others |
MDMB-CHMINACA, an indazole-based synthetic cannabinoid, acts as a potent agonist of the CB1 receptor. |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-01442 | DMBT1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Deleted in malignant brain tumors 1 protein, also known as glycoprotein 34, surfactant pulmonary-associated D-binding protein, DMBT1 and GP34, is a secreted protein which belongs to theDMBT1 family. DMBT1 contains 2CUB d... | |||
TMPH-00711 | BioH Protein, E. coli, Recombinant (His & Myc) | E. coli | E. coli |
The physiological role of BioH is to remove the methyl group introduced by BioC when the pimeloyl moiety is complete. It allows to synthesize pimeloyl-ACP via the fatty acid synthetic pathway through the hydrolysis of th... |